Top Markets
#1 Black Phoenix Black Phoenix +826.11%
#2 pipedog pipedog +30.60%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.23%
#4 SAFEcoin SAFEcoin +25.88%
#5 Beam Beam +22.88%
#6 PondCoin PondCoin +22.65%
#7 Bless Bless +21.86%
#8 Magma Finance Magma Finance +20.15%
#9 Prom Prom +17.56%
#10 YFSX YFSX +15.96%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Kedudukan dalam Saham #6243
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Harga Saham
$29.10
Modal Pasaran
$2.14B
Perubahan (1 hari)
-0.71%
Perubahan (1 tahun)
94.89%
Negara
US
Perdagangan Zymeworks Inc. (ZYME)

Kategori

Healthcare
Sejarah hasil dividen untuk Zymeworks Inc. (ZYME)
Hasil dividen (TTM) bagi Zymeworks Inc. (simbol saham: ZYME) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Zymeworks Inc. (ZYME) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH